In a nonimmunogenic, aggressive neuroblastoma model (AgN2a), PD-L1 expression is neither significant nor up-regulated in response to IFNγ and T-cell infiltrates, making the tumor more susceptible to vaccine therapy. Here, IFNG is linked to neuroblastoma.